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develops rapidly, and already after 48 h 
a beating heart and robust blood circula­
tion are readily observable under a ster­
eomicroscope.[2] Intravenously injected 
fluorescent nanoparticles (NPs) can there­
fore be directly observed at the whole 
animal level.[3] In addition, the availability 
of several fluorescent transgenic zebrafish 
lines with selectively labeled cells allows 
the assessment of NP interactions with 
important cells such as macrophages and 
endothelial cells.[3–5] These characteris­
tics, together with the much lower costs 
of maintenance in comparison to murine 
models, place the zebrafish in an ideal posi­
tion to become an important intermediate 
system for screening NPs between cell cul­
tures and mice. However, only semiquan­
titative methods for NP analysis have been 
applied until now, using confocal micro­
scopy, which is more time consuming than 
the use of a stereomicroscope and therefore 
allows fewer animals to be analyzed.[6,7] 
Among the parameters that are crucial for 
understanding NP behavior is the circulation time. This factor, 
which can also be studied in adult zebrafish, is essential for 
designing new nanomaterials since a long circulation time is 
associated with increased accumulation at diseased sites in 
The zebrafish embryo is a vertebrate well suited for visualizing nanoparticles 
at high resolution in live animals. Its optical transparency and genetic versa-
tility allow noninvasive, real-time observations of vascular flow of nanoparti-
cles and their interactions with cells throughout the body. As a consequence, 
this system enables the acquisition of quantitative data that are difficult to 
obtain in rodents. Until now, a few studies using the zebrafish model have 
only described semiquantitative results on key nanoparticle parameters. Here, 
a MACRO dedicated to automated quantitative methods is described for 
analyzing important parameters of nanoparticle behavior, such as circulation 
time and interactions with key target cells, macrophages, and endothelial cells. 
Direct comparison of four nanoparticle (NP) formulations in zebrafish embryos 
and mice reveals that data obtained in zebrafish can be used to predict NPs’ 
behavior in the mouse model. NPs having long or short blood circulation in 
rodents behave similarly in the zebrafish embryo, with low circulation times 
being a consequence of NP uptake into macrophages or endothelial cells. It is 
proposed that the zebrafish embryo has the potential to become an important 
intermediate screening system for nanoparticle research to bridge the gap 
between cell culture studies and preclinical rodent models such as the mouse.
The ORCID identification number(s) for the author(s) of this article 
can be found under https://doi.org/10.1002/smll.201906719.
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1. Introduction
The zebrafish embryo is rapidly becoming an attractive tool for 
screening nanoparticles.[1] This transparent vertebrate system 
© 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, 
Weinheim. This is an open access article under the terms of the Creative 
Commons Attribution License, which permits use, distribution and repro-
duction in any medium, provided the original work is properly cited.
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cancer and tuberculosis.[8–10] NP flow is greatly influenced by 
their uptake into blood macrophages (or monocytes). Moreover, 
for nanocarriers destined for the cancer therapy, uptake by 
macrophages is generally considered to decrease the chances 
of accumulation in tumor sites and is therefore considered a 
detrimental factor for therapeutic efficiency. However, some 
recent reviews and publications[11,12] suggest that direct tar­
geting of some macrophages may be desirable since a subset 
of these cells can be selectively recruited to diseased sites, such 
as tumor­associated macrophages (TAMs) in solid tumors.[13–15] 
Moreover, a number of intracellular pathogens reside and rep­
licate within macrophages, and several publications now recog­
nize the importance of targeting this cell type using NPs for 
fighting intracellular infections.[16,17] This approach has been 
reported for Mycobacterium marinum,[4] Francisella novicida,[18] 
Staphylococcus aureus,[19] and Salmonella enterica.[20]
Another important cell type that affects NP distribution is 
endothelial cells, which line the blood vessels through which 
NP flow along the body; by binding and taking up NPs, they are 
also capable of influencing their circulation times. This phe­
nomenon is not easily noticed in mouse models. Even in the 
zebrafish, only a few studies have described the uptake of NPs 
into endothelial cells in vivo.[3,21] Although uptake into endothe­
lial cells may be undesirable since they reduce circulation time, 
some researchers have added specific ligands to NPs in order to 
enhance this process, targeting specific diseases such as throm­
bosis and ischemia.[22,23]
Here, we describe methods to reliably quantify NP (see Table 1) 
circulation time and estimate the relative accumulation of NPs 
in macrophages or endothelial cells in the zebrafish embryo 
using a stereomicroscope and a user­friendly imageJ MACRO 
for automated image analysis. From the seven NP formula­
tions, four were selected to compare NP circulation time in 
zebrafish with mice.
2. Experimental Section
2.1. Zebrafish Embryo Handling
In this study, different strains of zebrafish embryos were used. 
For the manual analysis of the circulation (MACRO manual 
circulation), wild­type (WT) zebrafish embryos were used. For 
the automatic analysis of the circulation (MACRO automatic 
analysis) zebrafish expressing enhanced green fluorescence 
protein (EGFP) in the vasculature, Tg(fli1a:EGFP), were used; 
for the macrophage uptake analysis (MACRO macrophage 
uptake): Tg(mpeg1:cherry); and for the endothelial uptake 
analysis (MACRO endothelial uptake): double transgenic 
Tg(mpeg1:cherry) and Tg(fli1a:EGFP). After fertilization, 
the harvested embryos were kept at 28.5 °C in zebrafish egg 
water containing phenylthiourea (0.003%). All experiments 




Phosphatidyl choline (PC) was bought from Lipoid (product E 
PC­3), cholesterol (Chol) from Sigma, while phosphoethanola­
mine polyethylene glycol (PEG) 2000 (PE­PEG) and ATTO633­
1,2­dioleoyl­sn­glycero­3­phosphoethanolamine (DOPE) from 
ATTO­TEC, and biotinyl phosphoethanolamine (B­PE) from 
Avanti Lipids (products 880120P and 870282).
Procedure: 3 mL of chloroform and 5 µL of a solution 1 mg mL−1 
in ethanol of ATTO­633­labeled DOPE were added to a flask 
containing 2.4 mg of PC, 0.64 mg of Chol, and 0.69 mg of 
PE­PEG for PEGylated liposomes without biotin; 2.3 mg of PC, 
0.1 mg of B­PE, 0.64 mg of Chol, and 0.69 mg of PE­PEG for 
PEGylated liposomes with biotin; or 3.09 mg of PC and 0.64 mg 
of Chol for non­PEGylated liposomes.
These mixtures were dried using a rotatory evaporator in 
three consecutive steps: 150 mbar for 30 min, 80 mbar for 
30 min, and 16 mbar for 10 min. The dried phospholipids were 
then hydrated with 1 mL of phosphate­buffered saline (PBS) at 
70 °C and vortexed thoroughly. The resuspended mixture was 
then introduced in a gas­tight syringe which allowed the pas­
sage of the solution through filters of different sizes mounted 
on a mini extruder (Avanti lipids) at 70 °C. For liposomes 
100 nm PEG and 99 nm PEG biotin, a 0.05 µm pore size was 
used, while for liposomes 580 nm PEG and 623 nm NO PEG, 
a 0.8 µm filter was used. Liposomes were analyzed by dynamic 
light scattering (DLS) and a Zetasizer.
2.2.2. Poly(Sar-b-pCys(SO2Et)) NP
The preparation of core cross­linked polymeric micelles was 
adapted from the literature and modified.[24] Poly(sarcosine)­
b­poly((S­ethylsulfonyl)cysteine) (pSar225­b­pCys(SO2Et)31) was 
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Table 1. NPs used in the study. Hydrodynamic diameter measures the peak intensity obtained by DLS.
NP type Hydrodynamic diameter (Dh) [nm] Polydispersity index (PDI) Zeta potential [mV]
1) PEGylated liposomes 100 ± 0.55 0.04 ± 0.01 −3.54 ± 1.19
2) PEGylated liposomes with biotin 99 ± 0.58 0.07 ± 0.02 −1.49 ± 0.59
3) PEGylated liposomes 580.9 ± 12 0.4 ± 0.07 −1.53 ± 0.96
4) Non-PEGylated liposomes 623.7 ± 12 0.37 ± 0.06 −5.12 ± 0.81
5) Poly(DMA-b-BzKetAc) NP 65.8 ± 0.6 0.174 ± 0.0006 −28.9 ± 16
6) Poly(Sar-b-pCys(SO2Et)) NP 86.1 ± 0.93 0.131 ± 0.007 −1.94 ± 3.84
7) Poly(Sar-b-pCys(SO2Et)) NP 47.4 ± 0.45 0.094 ± 0.001 −3.36 ± 5.86
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dissolved in dimethyl sulfoxide (DMSO) at a concentration of 
7.5 g L−1 for 1 h. Next, 20 vol% of 1 × 10−3 m acetate buffer 
(pH 4.75) was added to adjust the concentration to 6.6 g L−1. 
The solution was left to equilibrate at room temperature for 5 h, 
followed by dialysis against 1 × 10−3 m acetate buffer (pH 4.75). 
The solution was filtered (GHP 450) and concentrated to 
6.6 g L−1 by spin filtration (Amicon Ultra, molecular weight 
cut­off (MWCO) = 3 kDa), yielding the micelle solution. For 
the preparation of nano particle type 7 (Table 1), DMSO and 
acetate buffer were equipped with 1 and 10 × 10−3 m thiourea, 
respectively. For cross­linking, in a separate flask, the lipona­
mide cross­linker was dissolved in ethanol at a concentration of 
β = 10 g L−1 and one equivalent of an aqueous solution of tris(2­
carboxyethyl)phosphine hydrochloride (TCEP·HCl) (50 g L−1) 
was added per disulfide. After 18 h, the cross­linker solution 
was added to the micelle solution at equimolar amounts of 
thiols per cysteines. The reaction mixture was allowed to 
stand at room temperature for 48 h. To remove residual cross­
linker and free polymer, the solution was dialyzed against 
DMSO and MilliQ water (MWCO = 6–8 kDa), followed by 
repetitive spin filtration (Amicon Ultra, MWCO = 100 kDa). 
For labeling, 1.0 equivalent of cyanine 5 NHS–ester stock solu­
tion (0.3 eq of Atto647N NHS­ester for NP7) in DMSO (5 g L−1) 
was added per polymer end group at pH 7.4 (adjusted with 1 
m NaHCO3 solution). After 72 h, excess dye was removed by 
repetitive spin filtration (Amicon Ultra, 100 kDa) using eth­
anol/water mixtures, and the final particle solution (in MilliQ 
water) was stored at 4 °C. The absence of free polymer and free 
dye was verified by gel permeation chromatography in hexa­
fluoro isopropanol.
The preparation of poly(N,N­dimethylacrylamide)­b­poly(2­((2­
(benzyloxy)propan­2­yl)oxy)ethyl acrylate) (poly (DMA­b­BzKetAc))) 
NP was performed according the method described in ref. [10].
2.3. Nanoparticle Injections
In order to intravenously inject the zebrafish embryos, NP 
solutions (4 mg mL−1) were loaded into borosilicate needles 
(GC100T­10, Harvard instruments) previously prepared using 
a micropipette puller (P­97, Sutter instruments). The needles 
were then attached to an Eppendorf Femtojet Express microin­
jector and controlled by a Narishige MN­153 micromanipulator. 
The injection of a precise quantity of NPs was done by careful 
manipulation of the pressure and time of injection. Once the 
desired volume was achieved, zebrafish embryos were anes­
thetized using zebrafish egg water supplemented with tricaine 
(0.02%). The injection of these embryo occurred on a Petri dish 
that had previously been filled with a solution of 2% agarose, 
which solidifies upon cooling. All the injections were made in 
the posterior cardinal vein at 2 days post fertilization.
2.4. Imaging of Zebrafish Embryos
Each zebrafish embryo injected with NPs was subsequently 
imaged at different times and in different channels depending 
on the type of analysis, using a Leica stereomicroscope 
DFC365FX (1.0× planapo lens) obtaining images of both 
the caudal region (120× magnification) and the whole fish 
(30× magnification). Prior to the imaging session, zebrafish 
were kept in Petri dishes wrapped in aluminum foil to avoid 
any possible photobleaching.
•	 For Circulation Time, Manual: Images were taken at 5 min 
and at 1, 4, 8, 24, 48, and 72 h, in transmission and the far red 
(Cy5, NP) fluorescence channel.
•	 For Circulation Time, Automatic: Images were taken at 5 min 
and at 1, 4, 8, 24, 48, and 72 h, in transmission, far red (Cy5, NP), 
and green (green fluorescence protein (GFP), endothelium) 
fluorescence channels.
•	 For Macrophage Uptake Evaluation, Automatic: Images were 
taken at 6 h in transmission, far red (Cy5, NP), and red 
(DsRed, macrophage) fluorescence channels.
•	 For Endothelial Uptake Evaluation, Automatic: Images were 
taken at 6 h in transmission, far red (Cy5, NP), red (DsRed, 
macrophage), and green (GFP, endothelium) fluorescence 
channels.
2.5. Functioning of the ImageJ MACRO
The ImageJ MACRO is available at https://github.com/
wohlmann/IJ_ZF_NP_Quantification.
Once started, the MACRO will ask, via a file handling dia­
logue, the folder where the images to be analyzed are stored 
and another folder, where the output results will become avail­
able. The Leica *.lif format or *.tif images will be accepted by 
the MACRO file handling.
As the MACRO includes various types of analyses, a second 
dialogue will enable the selection of the desired analysis as well 
as the definition of an individual channel order and assign­
ment. Analysis options are 1) circulation times, manual; 2) cir­
culation times, automatic; 3) macrophage uptake, automatic; or 
4) endothelial uptake, automatic. Fluorescent channels will be 
assigned to 1) transmission image, 2) NP, 3) macrophage, or 
4) endothelium fluorescence.
Additionally, the user has the option to verify the measure­
ments by analyzing quality control output images for the detected 
regions of interest (ROIs). If the images are not satisfactory, the 
levels of thresholding of each analysis can also be customized.
2.5.1. Circulation Time Analysis: Manual
After automatic sorting of the images depending on the magni­
fication, the MACRO will open and show the higher magnifica­
tion images (120× magnification images) as well as predefined 
rectangles of adaptable number and size to be positioned on the 
caudal vein by the user as indicated in Figure 1C. After posi­
tioning the rectangles on the caudal artery, the MACRO will 
measure the fluorescence intensity in this region and compare 
it to the fluorescence intensity of the whole fish (30× magnifi­
cation images) detected via its transmission signal. The results 
will be stored in two individual *.txt files (usable by spreadsheet 
software) for each measurement. The use of these values to 
determine NP circulation is explained in section “Quantifica­
tion of the Results Obtained Using the MACRO.”
Small 2020, 16, 1906719
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2.5.2. Circulation Time Analysis: Automatic
In this type of analysis, the MACRO is utilizing the vascu­
lature fluorescence (Tgfli1a:EGFP) signal to automatically 
detect the caudal vein region(120× magnification images). 
This detection was based on the muscle segments between 
the intersegmental vessels (ISVs) branching from the caudal 
vein and artery relying on an initial automated orientation of 
the image using the characteristic anatomical features of the 
zebrafish tail region. The rectangles for the measurement were 
adjusted to avoid inclusion of branching ISVs or local accu­
mulations using a NP signal threshold and particle analysis. 
As for the manual analysis, the fluorescence intensity of the 
whole animal was also analyzed (30× magnification images). 
The results were stored in two individual *.txt files (usable by 
spreadsheet software) for each measurement. The use of these 
values to determine NP circulation is explained in section 
“Quantification of the Results Obtained Using the MACRO.”
2.5.3. Macrophage Uptake Analysis: Automatic
In this analysis, the MACRO will first provide a thresholding 
of the NP signal (in 120× magnification images) in order to 
separate free NPs in the blood flow from the ones that have 
been taken up by cells; the latter, depending on the amount 
taken up, appear as brighter spots with higher density. Second, 
the macrophage signal was thresholded and overlapped with 
the NPs, and only the NPs within macrophages were analyzed 
for their intensity value. Similar to the NP circulation analysis, 
the overall NP fluorescence in the zebrafish was measured 
(30× magnification images) and the results were stored in two 
individual *.txt files (usable by spreadsheet software).
2.5.4. Endothelial Cells Uptake Analysis: Automatic
Identical to the macrophage uptake analysis, NPs and mac­
rophages were thresholded but in this case, the NPs within 
macrophages were eliminated before the fluorescence inten­
sity of the thresholded area occupied by the endothelium was 
measured for the remaining NP signals (120× magnification 
images). After the analysis of the whole zebrafish fluorescence 
(30× magnification images) in the NP channel, the results 
were stored in two individual *.txt files (usable by spreadsheet 
software) and will contain the estimated uptake of NPs by the 
endothelium in the caudal area and the overall fluorescence 
values in the whole zebrafish.
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Figure 1. Circulation of NPs in the zebrafish embryo, manual analysis. A) Acquisition of the zebrafish embryo at 48 h post fertilization in the transmis-
sion channel; the rectangular inset shows the area where the caudal region images were taken. B–E) Images of the caudal vein of zebrafish injected 
with fluorescent NPs (here 100 nm liposomes with PEG) imaged at different time points—B) 5 min, C)1 h, D) 4 h, and E) 24 h. B) The main blood 
components of the caudal region are shown by arrowheads (caudal artery and caudal vein). C) The rectangles used for quantification of fluorescence are 
shown (arrowheads); these are either manually or automatically placed on the caudal artery and in between intersegmental vessels. D,E) The decrease 
in fluorescence of the caudal artery (arrowheads) can be seen at 4 and 24 h. B–E, insets) The values for fluorescence in the artery are normalized rela-
tive to the overall NP fluorescence in the whole fish. Scale bars: A) 500 nm and B–E) 200 nm.
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2.6. Further Details About the MACRO
Throughout the MACRO script, several comment lines were 
used to explain in detail every command.
2.7. Quantification of the Results Obtained Using the MACRO
The output *.txt files obtained from the MACRO contained, 
for each zebrafish embryo, two values that will be used for 
the subsequent analyses: the “mean fluorescence value,” used 
for circulation analysis, and the “Raw Integrated Density” 
(RawIntDen), which is instead used for either macrophage or 
endothelial uptake and represents the sum of the pixel values 
in the selected area.
2.7.1. Circulation Analysis: Automatic and Manual
Raw Values: In this analysis for each time point the “mean fluo­
rescence intensity” of the artery (Martery, calculated from a 120× 
magnification image of the caudal region), and the “mean fluo­
rescence values” of the whole zebrafish (Mwhole, calculated from 
a 30× magnification image of the whole animal) were detected. 
Each point in the graph is represented by the result of the 
equation: Martery/Mwhole.
Percent Conversion: In order to convert results into per­
centages the value of each NP obtained at 5 min, Martery  
(5 min)/Mwhole (5 min) was considered the 100% estimate while 
the intensity of the background was considered to represent 



























2.7.2. Scoring Macrophage and Endothelial Uptake of Nanoparticles
While for circulation analysis, the mean values of intensity 
were used, for both macrophage and endothelial analyses Raw­
IntDen was utilized. The RawIntDen of each zebrafish caudal 
region (120× magnification images) was normalized by the 
overall fluorescence of the whole fish (also a RawIntDen value, 
30× magnification images) and multiplied by 100.
Macrophage Uptake: The fluorescence of the pixels rela­
tive to NP fluorescence in the macrophage selection was 
expressed as the RawIntDen value obtained in the results file 
for each zebrafish embryo (RIDmacrophages). The overall fluores­
cence intensity of NPs in the whole fish was also calculated as 
RawIntDen value (RIDwhole). In order to obtain the final value, 
RIDmacrophages was normalized by RIDwhole and multiplied 
by 100 as shown below









Endothelial Uptake: Just as for the macrophage analysis, the 
fluorescence of the pixels of the NPs which overlap with the 
endothelium signal was scored as a RawIntDen in the results 
file for each zebrafish (RIDendothelium). This value was normal­
ized by the overall NP fluorescence (RIDwhole) and multiplied by 
100 as shown below








2.8. Mouse Nanoparticle Circulation Analysis
Prior to the experiment, 6 week old male BALB/cAnNRj mice 
were divided into groups of six animals per cage according to 
the type of NPs (100 and 580 nm PEGylated liposomes, 623 nm 
non­PEGylated liposomes and 47 nm poly(Sar­b­pCys(SO2Et) 
NP) and time point for blood sampling (5 min, 4 h, 24 h, and 
72 h). Next, after 1 week of acclimatization, the mice received 
a single intravenous injection (200 µL) of NPs or with isotonic 
PBS solution (control). At the selected time points, the animals 
were placed under deep anesthesia (Isoflurane 5%) and after 
the ribcage was exposed, blood extraction was performed by 
cardiac puncture. This was followed by cervical dislocation to 
terminate the animals. Heparin­coated syringes and Eppendorf 
tubes were applied to prevent blood clotting. Samples were put 
on ice and protected from light by aluminum foil. 5 µL of blood 
from each animal was inserted into a fluorinated ethylene–pro­
pylene (FEP) tube, and an image in the far­red channel was 
taken with a Leica stereomicroscope DFC365FX. Mice receiving 
PBS were used as a background control. The NP circulation at 
each time point was then calculated as
Flowing NP, percent
Fluorescence time Background value









Values obtained at 5 min and subtracted of the background 
were considered the 100% value while the background corre­
sponded to the 0%. Mice experiments were approved by the 
Norwegian Food Safety Authority, Mattilsynet, FOTS ID: 20607.
2.9. Statistics Used
One­way analysis of variance (ANOVA) was used with Tukey’s 
multicomparison test to compare the different groups for macro­
phage and endothelial uptake. The test was used to assess if the 
values come from a Gaussian distribution was the Kolmogorov–
Smirnov test with Dallal–Wilkinson–Lille for P­value.
3. Results
3.1. Nanoparticle Circulation
The zebrafish embryo can be used to assess the circulation 
properties of NPs and here we have established two methods, 
Small 2020, 16, 1906719
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one manual and one automatic, to rapidly analyze the images. 
For this, we focused on the caudal region of the zebrafish 
which, being relatively thin, allows for better imaging and 
therefore more precise results compared to other sites in the 
zebrafish embryo. The main blood components of the caudal 
region are the caudal vein, the site of NP injection, and the 
caudal artery, the site of importance for the measurements 
(Figure 1B, arrowheads). In Figure 1, we show zebrafish 
embryos that had been injected with 100 nm PEG liposomes 
with images of the caudal area (Figure 1A) at different time 
points: 5 min (Figure 1B), 1 h (Figure 1C), 4 h (Figure 1D), and 
24 h (Figure 1E). In order to evaluate the circulation time, we 
measured the average fluorescence of the caudal artery over 
time, as this relatively big vessel facilitates the analysis due 
to its size and the absence of NP uptake by macrophages and 
lower uptake by endothelial cells, which occurs mainly in the 
caudal vein. As illustrated in Figure 1, the fluorescence signal 
due to flowing 100 nm PEGylated liposomes in the caudal vein 
decreases in time. Using the manual option of the MACRO, 
the user will place rectangles of predefined number and size 
on the caudal artery, between the intersegmental vessels (as 
shown in Figure 1B) for the analysis of the fluorescence signal. 
The MACRO will then automatically measure the fluorescence 
intensity of the resulting region as well as the whole fish region 
detected via its transmission signal.
In the automatic circulation analysis (Figure 2), it is nec­
essary to use transgenic zebrafish possessing fluorescent 
vasculature, here we used the Tg(fli1a:EGFP) strain. The infor­
mation obtained from the blood endothelium is used by the 
MACRO to detect the regions of the artery contained between 
two intersegmental vessels (Figure 2B). These regions will be 
analyzed while areas characterized by high fluorescence, due 
to endothelial uptake, will be eliminated from the quantifica­
tion, as shown in Figure 2C. As for the previous analysis, the 
mean fluorescence intensity in these areas will be measured 
(Figure 2D) together with the total fluorescence of the whole 
embryo; the relative values of each zebrafish are provided in 
two separate *.txt files.
In order to plot the circulation in time (5 min, 1 h, 4 h, 8 h, 24 h, 
48 h, and 72 h), the average fluorescence signal in the artery 
is normalized relative to the overall fluorescence (see “Experi­
mental Section” for details), resulting in the values shown in 
Figure 3. These initially calculated values (Figure 3A) are then 
converted to percentages (Figure 3B–D). PEGylated liposomes 
of 100 and 580 nm circulate well, with longer circulation times 
evident for the smaller 100 nm liposomes which, even after 
3 days, had about 5% of the NPs still in circulation. The lack of 
a PEG layer or the presence of biotin decreases the circulation 
times of the liposomes, with the former being removed from 
the blood flow already 8 h after injection while the latter cease 
to circulate at about 48 h (Figure 3B,C). Further, NPs being 
expected to be long circulating, possessing a different surface 
chemistry such as polysarcosine and polyDMA ((poly(Sar­b­
pCys(SO2Et)) and poly(DMA­b­BzKetAc) NP), show relatively 
longer circulation times, especially the 41 nm NPs ((poly(Sar­
b­pCys(SO2Et)) and 65 nm poly(DMA­b­BzKetAc). After 3 days, 
these embryos still had 15% and 11.5% of the injected NPs still 
in circulation (3D).
3.2. Nanoparticle Circulation Time in Zebrafish and Mouse
So far, our analysis showed that NPs known from mice 
experiments to have short circulation times (non­PEGylated 
Small 2020, 16, 1906719
Figure 2. Circulation of NPs in the zebrafish embryo, automatic analysis. This image shows the steps performed by the MACRO for the analysis of the 
fluorescence in the caudal artery. A) The image processing of zebrafish injected with fluorescent NPs (99 nm PEGylated liposomes with biotin) utilizes 
B) the fluorescent signal of the vasculature to identify the caudal artery. C) Fluorescence due to NP uptake in the artery is removed, and D) regions 
in between intersegmental vessels are automatically detected to calculate the relative fluorescence. The results are then normalized relative to the 
fluorescence of the whole fish (panel (D), lower right image).
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liposomes) or long circulation (PEGylated liposomes, poly­
sarcosine NP, and polyDMA NP) behaved similarly in the 
zebrafish model. We therefore asked whether the zebrafish 
embryo could be used to predict NP circulation in mice; for this, 
we selected four of the analyzed NP mixtures (100 and 580 nm 
PEGylated liposomes, 623 nm non­PEGylated liposomes, and 
47 nm (pSar­b­pCys(SO2Et)) NP) and assessed their circula­
tion in mice by estimating the residual fluorescence at four 
selected time points, 5 min, 4 h, 24 h, and 72 h. The com­
parison between these two sets of data is shown in Figure 4. 
In both animal models, non­PEGylated liposomes of about 
623 nm were removed from the circulation in a matter of a few 
hours. PEGylated liposomes of 100 nm circulated better in both 
animal models than the 580 nm PEGylated liposomes, although 
in zebrafish both these liposomes circulated for longer times. 
The nanoparticles which performed best in both models were 
the 47 nm (pSar­b­pCys(SO2Et)) NP) with comparable circula­
tion at 72 h. In the zebrafish, these NPs, after the first decline, 
remain stable in circulation, while in the mouse we observed a 
moderate decline throughout all the time points.
Small 2020, 16, 1906719
Figure 3. Quantification of the NP circulation times in zebrafish embryos. A) Raw values obtained by dividing the average fluorescence in the caudal 
artery with the total fluorescence. B–D) Values converted in percentages. B) PEGylated 100 nm liposomes are compared to 580 nm PEGylated liposomes 
and 623 non-PEGylated ones. C) The presence of biotin in PEGylated liposomes of about 100 nm is evaluated. D) NPs with three different surfaces 
known to allow long circulation (PEG, polyDMA, and polysarcosine) are compared. Bars indicate standard deviation, N ≥ 3.
Figure 4. NP circulation in zebrafish embryos and mice. A) The circulation of the four selected NPs in zebrafish embryo: 100 and 580 nm PEGylated 
liposomes, 623 non-PEGylated liposomes, and 47 nm (pSar-b-pCys(SO2Et)) NP. B) The circulation of the same NPs in the mouse model. N ≥ 4.
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3.3. Macrophage Uptake
The zebrafish embryo is an effective system to evaluate the 
uptake of NPs by macrophages (Figure 4A) which appear 
during development already by 24 h post fertilization;[25] for 
this evaluation it is essential to use a transgenic reporter line 
with fluorescent macrophages, here Tg(mpeg1:mcherry). The 
MACRO will first threshold the NP signal (Figure 5B), a neces­
sary step in order to eliminate NPs that are still flowing from 
the evaluation, so that only the brightest NP accumulations are 
scored. The next step is the thresholding of the macrophages 
(Figure 5C), so that only the area occupied by these cells will 
be overlapped with that of the NPs (Figure 5D). Only the NPs 
found in macrophages are thereby scored for their fluorescence 
signals. As for all described analyses, this MACRO also evalu­
ates the fluorescence signal of the whole fish and will save the 
measurements in two *.txt files.
Unlike for the circulation analysis, here the values are 
calculated as total rather than average fluorescence (RawIntDen 
rather than mean; see the “Experimental Section” for further 
details). For this, the macrophage uptake scoring is normal­
ized relative to the overall zebrafish NP fluorescence. PEGylated 
liposomes of 100 and 580 nm, both poly(DMA­b­BzKetAc) NP 
and poly(Sar­b­pCys(SO2Et)) NP, exhibit a very low uptake by 
macrophages (all with a score below 10), while non­PEGylated 
623 nm liposomes and biotinylated liposomes 99 nm gave high 
values scoring over 20 and 30, respectively (Figure 6).
3.4. Endothelial Uptake of NPs
The use of the zebrafish line Tg(fli1a:EGFP) crossed with 
Tg(mpeg1:mcherry) allows for estimation of NPs uptake by 
endothelial cells (Figure 7A), a prominent characteristic of sev­
eral NPs that we have tested in our zebrafish system. As for 
macrophage uptake, both NPs and macrophages have to be 
thresholded (Figure 7B,C), but in this case the signal derived 
from macrophage accumulations is removed (Figure 7D) and 
the remaining signal overlapped with that of the thresholded 
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Figure 5. Macrophage uptake of NPs. Illustration of the steps undertaken by the MACRO for macrophage analysis to calculate the uptake of NPs. 
A) Zebrafish embryos injected with 623 nm liposomes without PEG (white) and fluorescent macrophages (red) are used for the analysis. B,C) NPs and 
macrophages are first thresholded, and D) their signals subsequently overlapped for analysis. The obtained values are normalized by the fluorescence 
of the whole zebrafish (panel (D), lower image).
Figure 6. Quantification of NP uptake in the zebrafish by macrophages. 
The fluorescence scores of each NP are reported in arbitrary units. 
Statistics: one-way ANOVA with Tukey’s multicomparison test: * = P ≤ 0.05, 
**** = P ≤ 0.001. Bars indicate standard deviation, N ≥ 6.
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endothelium in order to provide the final score (Figure 7E,F). 
As for macrophage uptake, the scored fluorescence intensity 
in the caudal vein has to be normalized relative to the whole 
fish total fluorescence signal; both these values are provided, 
for each zebrafish, in two *.txt files, one containing endothelial 
uptake score and the other the overall fluorescence signal.
Our results show that long circulating NPs such as PEGylated 
100 nm liposomes, poly(DMA­b­BzKetAc) NPs, and both 
poly(Sar­b­pCys(SO2Et)) NPs and for 623 nm non­PEGylated 
liposomes display a low value for endothelial cell uptake below 
2. Biotinylated liposomes 99 and 580 nm liposomes instead 
exhibit large uptake values by endothelial cells which are signif­
icantly higher than the values of all other tested NPs (Figure 8) 
and above the value of 20.
4. Discussion
The vertebrate model zebrafish and the mouse model exhibit 
high genetic similarity with humans (70% of mouse and 82.2% 
of the zebrafish genes having a human orthologue)[26] while sev­
eral important organs are also conserved in the fish, including 
the heart, brain, liver, kidney, pancreas, and intestine. Although 
the mouse remains the preclinical model of choice, in the field 
of nanomedicine, the zebrafish embryo possesses a number of 
advantages over the mouse model: 1) in the early development 
stages, the zebrafish is transparent, allowing precise imaging 
of the whole animal. 2) Several strains of this fish having flu­
orescent cell types are available so that their interactions with 
NPs can be easily studied. 3) The zebrafish maintenance costs 
are much lower than for mice with the estimate, from Boston 
University, of 1.05 $ for housing a single mouse while 0.25 $ 
for an entire tank (≈30 adults) of zebrafish.[27] 4) In addition, 
major differences are evident when it comes to the typical vol­
umes of NPs that one needs to inject for experiments, allowing 
the researchers to save valuable material. Assuming the average 
weights of 1 mg for a zebrafish embryo and about 25 g for a 
mouse, 1 nL NP solution in zebrafish is equivalent to 25 µL in 
the mouse, a volume 25 000 higher. Despite these advantages, 
until now the use of the zebrafish has mostly been limited to 
the analysis of the toxic effects of NPs, especially on develop­
ment.[28] An important limitation of the vast majority of these 
studies is that the NPs to be tested are administered only via the 
water bathing the fish which means the investigator has no con­
trol over the dose of NPs that access the vital organs. The only 
reliable method to overcome this is to microinject the NPs into 
the embryo, an operation which can be performed in different 
locations such as the yolk sac, the vasculature, intramuscular, 
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Figure 7. Endothelial uptake of NPs. Illustration of the steps undertaken by the endothelial analysis MACRO. A) Zebrafish embryos injected with 
99 nm PEGylated liposomes with biotin (white) and fluorescent macrophages (red) as well as endothelium (green) are used for the analysis. B) NPs 
and C) macrophages are first thresholded. D) The NP signals in macrophages regions are deleted. Subsequently the signal of the endothelium is 
E) thresholded and F) overlapped to the residual NP measuring their fluorescence. The obtained values are normalized by the fluorescence of the 
whole zebrafish (panel (F), lower image).
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or into the hindbrain. In an earlier study, we have used vascular 
injection to analyze the toxicity of thioridazine, an antipsychotic 
drug whose promising therapeutic effects against Mycobacte-
rium tuberculosis is hindered by its cardiotoxicity. We showed 
that although the free drug was highly toxic to fish embryos, the 
same drug concentration, encapsulated in poly(lactic­co­glycolic 
acid) (PLGA) NPs, resulted in no detectable toxicity, using 
multiple parameters.[29]
Over the past decade we have injected a significant number 
of different types of fluorescent NPs into zebrafish embryos 
and realized that for most NP types reproducible patterns of 
localization could be rapidly detected within a few hours after 
their injection. After intravenous injection, these patterns, at 
the extreme were, long or short circulation times and uptake 
or not by macrophages or vascular endothelial cells. Uptake by 
endothelial cells would be especially difficult to determine in 
mice. We were aware that if the zebrafish system is to become a 
standard model for screening NPs prior to their testing in pre­
clinical mouse models, it would be essential to have available 
standardized methods for quantification of these different NP 
patterns. With this goal in mind, we introduce here a robust 
and simple methodology for reproducible quantification of 
these patterns for fluorescent NPs relative to their circula­
tion times, and association with macrophages and endothelial 
cells. These parameters are of paramount importance when 
designing NPs for the treatment of different diseases. To our 
knowledge, the only method described in the literature to inves­
tigate NP circulation in zebrafish is the semiquantitative anal­
ysis proposed by Sieber et al.,[7] evaluating what they referred to 
as “circulation factor.” That parameter is in fact not the actual 
NP circulation time but rather the ratio, limited to the caudal 
region, of NPs free flowing in the blood and the caudal vascu­
lature area. In our method, however, we focused on the NP cir­
culation by measuring the decrease of the average fluorescence 
in the caudal artery, a value which is then divided by the NP 
fluorescence in the whole zebrafish embryo. This last step of 
normalization, after transformation into percentages, allows 
us to obtain direct comparisons between different NPs and 
even when having different fluorescence intensity. Our method 
therefore provides an unbiased estimate of the NP circulation 
time.
With the method we introduced here, we analyzed NPs with 
a variety of sizes and materials. Our results clearly show that 
the behavior of NPs possessing a surface coating known to 
allow for long circulation times (in the range 1–3 days) in mam­
malian models, such as PEG, polysarcosine, polyDMA,[30–32] 
show the same behavior in the zebrafish. Importantly, a direct 
comparison of four selected NP formulations (100 and 580 nm 
PEGylated liposomes, 623 non­PEGylated liposomes, and 
47 nm (pSar­b­pCys(SO2Et)) NP) in the mouse and the zebrafish 
model revealed that the latter is able to predict with reasonable 
accuracy the pattern of circulation in mice. We believe that this 
animal model could be used in the future as an intermediate 
animal model, prior to the mouse, for testing different NPs 
having, for example, different surface chemistry. In the fish this 
could be done at a fraction of the cost in a shorter time.
We also quantified the uptake by macrophages in the zebrafish 
embryo and observed that NPs lacking surface coats such as PEG 
or polysarcosine and polyDMA, which are known to be rapidly 
removed from the circulation by macrophages[33] also exhibit the 
same behavior in zebrafish embryos; this was evident with our 
PLGA[4] or non­PEGylated liposomes in this study. Importantly, 
macrophage uptake, albeit greatly reduced for NPs containing 
PEG, polysarcosine and polyDMA, could still be observed in all 
tested NPs. The endothelial analysis also showed the importance 
of this cell type in determining the circulation of NPs. In par­
ticular, the presence of biotin in 100 nm PEGylated liposomes 
resulted in a high uptake by the endothelium, a behavior also 
observed in 580 nm PEGylated liposomes, a factor that could 
explain the reduced circulation times observed for these NPs 
when compared to plain 100 nm PEGylated liposomes. The 
mechanism that allows these NPs to be so efficiently taken up by 
the endothelial cells remains to be identified.
In this study, we did not address the uptake of NPs by neutro­
phils as; in our experience,[4,18] these cells play only a marginal 
role in the uptake of the NPs that we have tested after intra­
venous administration. However, in contrast to macrophages, 
neutrophils are known to be highly active in the uptake in sur­
face­bound particles, such as bacteria following intramuscular 
injection of Escherichia coli.[34] Our MACRO could be easily cus­
tomized to study this type of uptake since the zebrafish can be 
easily injected intramuscularly with NPs.
While our analysis was limited by uptake of NPs in mac­
rophages and endothelial cells, the use of the method and 
MACRO that we have introduced here is by no mean restricted 
to these cells and could be easily adapted for analysis of any 
cell or tissue that can be labeled with a fluorescent protein. Of 
particular interest in the NP field would be the use of zebrafish 
Figure 8. Quantification of NP uptake in the zebrafish by endothe-
lial cells. The fluorescence scores of each NP are reported in arbitrary 
units. Statistics: one-way ANOVA with Tukey’s multicomparison test: 
*** = P ≤ 0.005. Bars indicate standard deviation, N ≥ 5.
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embryos with fluorescent liver,[35] kidney,[36] or heart.[37] 
Moreover, instead of injecting NPs, it would be possible to 
inject different types of bacteria and analyze their behavior 
in a vertebrate host based on quantification of their preferred 
cell or tissue niche. The generic method that we introduce 
here strengthens the importance of the zebrafish model as a 
screening tool for characterizing any type of fluorescent nano­
particles and thereby selecting a restricted number for the more 
time­consuming and expensive analysis in mammalian preclin­
ical models.
5. Conclusion
The zebrafish embryo is rapidly becoming an important animal 
model for testing nanosized drug carriers and is capable of 
greatly reducing the number of formulations to be tested fur­
ther in rodent animal models. Our study provides a robust 
instrument for unbiased and automated analysis of essential 
NP parameters during intravascular flow, thereby extending the 
advantages of the zebrafish embryo in NP research.
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